SSTI Flashcards
treatment of mild impetigo
topical antibiotics eg:
- mupirocin BD x 5/7
empiric treatment of severe impetigo/ all ecthyma
- cephalexin 250-500mg PO QDS* x1/52
- cloxacillin 250-500mg PO QDS x1/52
- (penicillin allergy): clindamycin x1/52
culture directed treatment of severe impetigo/ all ecthyma
S pyogenes: penicilin VK 250-500mg PO QDS x1/52
MSSA:
- cephalexin 250-500mg PO QDS* x1/52
- cloxacillin 250-500mg PO QDS x1/52
mainstay of treatment for purulent SSTI
incision and drainage (I&D)
identify and treat mild, non purulent cellulitis/erysipelas
no signs of systemic infections (SIRS)
cover: strepto spp
treatment (PO)
- Penicillin VK
- Cloxacillin
- Cephalexin
- Clindamycin
identify and treat moderate, non purulent cellulitis/erysipelas
org to cover: strept +staph if 1 SIRS: PO antibiotic 1. Penicillin VK 2. Cloxacillin 3. Cephalexin 4. Clindamycin
if >2 SIRS or PO Tx fail: IV
- Cefazolin
- Penicillin G
- Clindamycin
identify and treat severe, non-purulent cellulitis/erysipelas
org to cover: strept + staph+ gram neg (p. aeruginosa)
if >2 SIRS + BP<100-60/ rapid progression/immuno/comorbidities : IV
- Pipe-Tazo
- Cefepime
- Meropenem
MRSA risk factor: (immuno, critically ill, previous failure to non MRSA AB)- IV Tx:
- vanco (preferred- narrower)
- dapto
- Linezolid
identify and treat mild, purulent cellulitis/erysipelas
organism: Strep& staph no SIRS: PO 1. Cephalexin 2. Cloxacillin 3. Clindamycin
MRSA risk factor- (immuno, critically ill, previous failure to non MRSA AB) PO antibiotics Tx:
- Trimetho-Sulfametho
- Clindamycin
- Doxycycline
identify and treat moderate, purulent cellulitis/erysipelas
org: strep+staph
if 1 SIRS: treat like mild, PO
- Cefalexin
- Cloxacillin
- Clindamycin
if >2 SIRS: IV antibiotics
- Cefazolin
- Cloxacillin (milder +MRSA)
- Clindamycin (milder +MRSA)
MRSA risk- (immuno, critically ill, previous failure to non MRSA AB) IV antibiotics:
- vanco
- dapto
- linezolid
identify and treat severe, purulent cellulitis/erysipelas
indications: >2SIRS, <100/60bpm, rapid progression, immuno, comorbidities
Organism: strepo + straph + gram neg (p aeruginosa)
Tx: IV antibiotics:
- Pipe-tazo
- Cefepime
- Meropenem
MRSA risk factors (immuno, critically ill, previous failure to non MRSA AB): IV
- Vanco
- Dapto
- Linezolid
identify and treat mild DFI
infection of skin and SC tissue + erythema <=2cm around ulcer + no signs of systemic infection (no SIRS)
organism: strep/staph
treatment: PO antibiotics
1. Cephalexin
2. Cloxacillin
3. Clindamycin
MRSA risk factors (immuno, critically ill, previous failed AB without MRSA coverage): PO antibiotics
- Trimetho/Sulfametho
- Clindamycin
- Doxycycline
duration: 1-2w
identify and treat Moderate DFI
infection of skin and SC tissue + erythema >2cm around ulcer + no signs of systemic infection (no SIRS)
organism: strep/staph + gram neg (p.aeruginosa) + anaerobes
treatment: IV antibiotics
1. Amoxi/clav (dont need anaerobic coverage)
2. ceftriaxone
3. ertapenem (not really preferred; keep for esbl)
MRSA risk: IV
- vanco
- dapto
- linezolid
Anaerobes
- metronidazole
- clindamycin
duration: 1-3w
identify and treat severe DFI
signs of systemic infection (with SIRS)
organism: strep/staph + gram neg (p.aeruginosa) + anaerobes
Tx: initial IV
- pipe/tazo
- cefepime
- meropenem
MRSA risk: IV
- vanco
- Daptop
- Linezolid
anaerobic: IV
1. metronidazole
2. clindamycin
duration: 2-4w
duration of DFI tx
mild: 1-2w
moderate: 1-3w
severe: 2-4w
surgery remove all infected bone: 2-5d
surgery with residual infected soft tissues: 1-3w
surgery with residual viable bone: 4-6w
no surgery/ dead bone: >=3mth
dont continue AB until wound heals completely
protective factors of skin
- drug surface (no moisture, prevent growth)
- fatty acids
- Acidic pH (~5.6)
- renewal of epidermis (skin shed)
- low temperature (inhibit bacteria growth)
predisposing factors
- high bacteria innocula
- excessive moisture
- reduced blood supply
- presence of bacteria nutrients
- poor hygiene
- sharing of personal items
least to most deep SSTI
impetigo (epidermis) ecthyma (dermis) erysipelas (dermis) furuncles (hair follicles) carbuncles (hair follicles) cellulitis (subcutaneous fat) necrotising fascilitis (fascia) myotitis (muscle)
how is impetigo and ecthyma usually managed and classified
outpatient; severity: mild depth of infection: uncomplicated discharge: purulent/ non purulent microbiology: primary anatomical site: epidermis/ up to the dermal-epidermal junction
scarring is common in ecthyma or impetigo
ecythma, it is deeper than impetigo
causative agent of impetigo/ecthyma
staphlococcus aureus
B-hemolytic streptococci (pyrogenes)
bullous form caused by toxin-producing strains of S. aureus
is culture a need for ecthyma or impetigo
it is optional; may culture if pus, but usually reasonable to treat without culture
empirical coverage for ecthyma/impetigo
S. aureus and B-hemolytic streptococci (cover both since unsure which is the actual causative organism)
furuncles
infection of the hair follicles, extended through the dermis, inflammatory nodule
carbuncles
involved a few adjacent follicles; form a small abscess, , larger and deeper, multiple hair follicles may be involved